U.V. Analytical Method Development and Validation of Piroxicam Bulk API
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.6, No. 4)Publication Date: 2023-07-15
Authors : Mohd Fareed shaikh; Siddhi Pise; Mohd Anas Khan; Jaya Agnihotri;
Page : 5-7
Keywords : ;
- U.V. Analytical Method Development and Validation of Piroxicam Bulk API
- ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATIONOF BUDESONIDE AND FORMOTEROL IN BULK AND DOSAGE FORM USING RP-HPLC METHOD
- Analytical Method Development and Validation for the Estimation of the Azilsartan Medoxamil by RP HPLC Method in Bulk and Pharmaceutical Dosage Form
- Novel Analytical Method development and validation for estimation of bromofenac sodium in bulk and pharmaceutical dosage form by Derivative and AUC spectroscopic method
- Sensitive Analytical Method Development and Validation of Ritonavir Bulk drugs by RP-HPLC
Abstract
The study was aimed to developed a sensitive ultraviolet (UV) spectrophotometric method for the determination of piroxicam bulk API. The samples and standards were prepared in 0.1M methanolic HCL and the drug was quantified at a lambda max of 333nm using a double beam UV spectrophotometer. The range of linearity for the method was found to be between 2-14 μg/ml, which followed Beer-Lambert's law and the regression coefficient near 1. The validity of the method was extensively tested using statistical parameters such as linearity, range accuracy, precision, LOD and LOQ. The proposed method performed well in terms of mean values and standard deviations. The method was found to be accurate, precise, specific, and fast, making it a reliable way to analyze Piroxicam
Other Latest Articles
- A Case Report of Insulin Edema Syndrome
- Case Report of Hemoperitoneum from Discal Hemorrhage
- Validating the Selection Process of Healthy Control Group Based on Apparently Healthy Volunteers
- Occurrence of Microbial Resistence in Blood Cultures in a Teaching Hospital before and after the Restrictive Measure for the Commercialization of Antimicrobials in Brazil
- Endoplasmic Reticulum Stress as Therapeutic Target against Hypertension
Last modified: 2023-07-12 19:49:30